FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011567726> ?p ?o ?g. }

• W2011567726 endingPage "335" @default.
• W2011567726 startingPage "330" @default.
• W2011567726 abstract "An updated worldwide web-based survey assessed the real-life clinical practices regarding luteal-phase supplementation (LPS) in assisted reproduction. This survey looked for changes since a former survey conducted nearly 3 years earlier. The survey questions were: If you support the luteal phase, when do you start the regimen you are using?; Which agent/route is your treatment of choice to support the luteal phase?; If you use vaginal progesterone, which formulation do you use?; and How long you continue progesterone supplementation if the patient conceived? Data were obtained from 408 centres (82 countries) representing 284,600 IVF cycles/year. The findings were: (i) most practitioners (80% of cycles) start LPS on the day of egg collection; (ii) in >90%, a vaginal progesterone product is used (77% as a single agent and 17% in combination with i.m. progesterone), while human chorionic gonadotrophin as a single agent for LPS is not being used at all; and (iii) in 72% of cycles, LPS is administered until 8–10 weeks’ gestation or beyond. When compared with the initial survey, the results of this survey are encouraging as there is a clear shift towards a more unified and evidence-based approach to LPS in IVF cycles.This updated worldwide web-based survey assessed the actual real-life clinical practices regarding luteal-phase supplementation (LPS) in assisted reproduction. Specifically, this survey looked for changes since an initial survey conducted nearly 3 years earlier. The survey included the following questions: If you support the luteal phase, when do you start the regimen you are using?; Which agent/route is your treatment of choice to support the luteal phase?; If you use vaginal progesterone, which formulation do you use?; and How long you continue progesterone supplementation if the patient conceived? Data from 408 centres in 82 countries representing a total of 284,600 IVF cycles/year were included. Most practitioners (80% of cycles) start LPS on the day of egg collection and in more than 90% a vaginal progesterone product is used for LPS (in 77% as a single agent and in 17% in combination with i.m. progesterone). As a single agent for LPS, human chorionic gonadotrophin is not being used at all. Regarding the duration of supplementation, in 72% of cycles, LPS is administered until 8–10 weeks’ gestation or beyond. When compared with the initial survey from 2009, the results of this updated survey are encouraging as there is a clear shift towards a more unified and evidence-based approach to luteal-phase support in IVF cycles. Nevertheless, although there is no firm evidence supporting the continuation of LPS after the demonstration of fetal heart beat on ultrasound, this remains the common practice of the majority of assisted reproduction centres worldwide." @default.
• W2011567726 created "2016-06-24" @default.
• W2011567726 creator A5002465997 @default.
• W2011567726 creator A5017339168 @default.
• W2011567726 creator A5028575499 @default.
• W2011567726 creator A5076980114 @default.
• W2011567726 creator A5084304351 @default.
• W2011567726 date "2014-03-01" @default.
• W2011567726 modified "2023-10-02" @default.
• W2011567726 title "Luteal-phase support in assisted reproduction treatment: real-life practices reported worldwide by an updated website-based survey" @default.
• W2011567726 cites W1672109574 @default.
• W2011567726 cites W1841060429 @default.
• W2011567726 cites W1980372626 @default.
• W2011567726 cites W1981479931 @default.
• W2011567726 cites W2000912151 @default.
• W2011567726 cites W2011182330 @default.
• W2011567726 cites W2014187827 @default.
• W2011567726 cites W2035670423 @default.
• W2011567726 cites W2039002801 @default.
• W2011567726 cites W2042761896 @default.
• W2011567726 cites W2055065105 @default.
• W2011567726 cites W2057941571 @default.
• W2011567726 cites W2067104187 @default.
• W2011567726 cites W2101329303 @default.
• W2011567726 cites W2108947604 @default.
• W2011567726 cites W2111841803 @default.
• W2011567726 cites W2122664063 @default.
• W2011567726 cites W2126082098 @default.
• W2011567726 cites W2129885967 @default.
• W2011567726 cites W2139500938 @default.
• W2011567726 cites W2152423098 @default.
• W2011567726 cites W2155007716 @default.
• W2011567726 cites W2171166999 @default.
• W2011567726 cites W2272486413 @default.
• W2011567726 cites W2290871063 @default.
• W2011567726 cites W86353481 @default.
• W2011567726 doi "https://doi.org/10.1016/j.rbmo.2013.10.022" @default.
• W2011567726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24447959" @default.
• W2011567726 hasPublicationYear "2014" @default.
• W2011567726 type Work @default.
• W2011567726 sameAs 2011567726 @default.
• W2011567726 citedByCount "58" @default.
• W2011567726 countsByYear W20115677262014 @default.
• W2011567726 countsByYear W20115677262015 @default.
• W2011567726 countsByYear W20115677262016 @default.
• W2011567726 countsByYear W20115677262017 @default.
• W2011567726 countsByYear W20115677262018 @default.
• W2011567726 countsByYear W20115677262019 @default.
• W2011567726 countsByYear W20115677262020 @default.
• W2011567726 countsByYear W20115677262021 @default.
• W2011567726 countsByYear W20115677262022 @default.
• W2011567726 countsByYear W20115677262023 @default.
• W2011567726 crossrefType "journal-article" @default.
• W2011567726 hasAuthorship W2011567726A5002465997 @default.
• W2011567726 hasAuthorship W2011567726A5017339168 @default.
• W2011567726 hasAuthorship W2011567726A5028575499 @default.
• W2011567726 hasAuthorship W2011567726A5076980114 @default.
• W2011567726 hasAuthorship W2011567726A5084304351 @default.
• W2011567726 hasConcept C126322002 @default.
• W2011567726 hasConcept C131872663 @default.
• W2011567726 hasConcept C143228043 @default.
• W2011567726 hasConcept C15744967 @default.
• W2011567726 hasConcept C173481278 @default.
• W2011567726 hasConcept C187785154 @default.
• W2011567726 hasConcept C2781413609 @default.
• W2011567726 hasConcept C29456083 @default.
• W2011567726 hasConcept C71924100 @default.
• W2011567726 hasConcept C75630572 @default.
• W2011567726 hasConceptScore W2011567726C126322002 @default.
• W2011567726 hasConceptScore W2011567726C131872663 @default.
• W2011567726 hasConceptScore W2011567726C143228043 @default.
• W2011567726 hasConceptScore W2011567726C15744967 @default.
• W2011567726 hasConceptScore W2011567726C173481278 @default.
• W2011567726 hasConceptScore W2011567726C187785154 @default.
• W2011567726 hasConceptScore W2011567726C2781413609 @default.
• W2011567726 hasConceptScore W2011567726C29456083 @default.
• W2011567726 hasConceptScore W2011567726C71924100 @default.
• W2011567726 hasConceptScore W2011567726C75630572 @default.
• W2011567726 hasIssue "3" @default.
• W2011567726 hasLocation W20115677261 @default.
• W2011567726 hasLocation W20115677262 @default.
• W2011567726 hasOpenAccess W2011567726 @default.
• W2011567726 hasPrimaryLocation W20115677261 @default.
• W2011567726 hasRelatedWork W1966020547 @default.
• W2011567726 hasRelatedWork W2011567726 @default.
• W2011567726 hasRelatedWork W2034542604 @default.
• W2011567726 hasRelatedWork W2065856818 @default.
• W2011567726 hasRelatedWork W2412036944 @default.
• W2011567726 hasRelatedWork W2748952813 @default.
• W2011567726 hasRelatedWork W2899084033 @default.
• W2011567726 hasRelatedWork W3031052312 @default.
• W2011567726 hasRelatedWork W4231022123 @default.
• W2011567726 hasRelatedWork W2104160251 @default.
• W2011567726 hasVolume "28" @default.
• W2011567726 isParatext "false" @default.
• W2011567726 isRetracted "false" @default.
• W2011567726 magId "2011567726" @default.
• W2011567726 workType "article" @default.